CATHERINE C. TURKEL Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for CATHERINE C. TURKEL.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of CATHERINE C. TURKEL. CATHERINE C. TURKEL is a Chief Development Officer in Novus Therapeutics, Inc. ($TKAI) and a President in Novus Therapeutics, Inc. ($TKAI).

Address: C/O NOVUS THERAPEUTICS, INC. 19900 MACARTHUR BLVD., SUITE 550 IRVINE 92612 CA

Companies in which CATHERINE C. TURKEL is an Insider

Eledon Pharmaceuticals, Inc.

Trading Symbol: ELDN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CATHERINE C. TURKEL: President, Chief Development Officer
Holdings: 90,576 shares
Current Value: $82,424
Latest Transaction: Mar 20 2020
$ELDN Market Capitalization: $20.25M
$ELDN Previous Close: $0.91

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of CATHERINE C. TURKEL

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 20 2020NVUSNovus Therapeutics ...TURKEL CATHERINE C.PresidentOption ExerciseA0.26100,00026,000100,000
Sep 30 2019NVUSNovus Therapeutics ...TURKEL CATHERINE C.PresidentOption ExerciseA0.6775,00050,25075,000
Sep 30 2019NVUSNovus Therapeutics ...TURKEL CATHERINE C.PresidentOption ExerciseA0.6775,00050,25075,000
May 22 2019NVUSNovus Therapeutics ...TURKEL CATHERINE C.PresidentSellS1.911,9143,65888,66290.6 K to 88.7 K (-2.11 %)
May 22 2019NVUSNovus Therapeutics ...TURKEL CATHERINE C.PresidentSellS1.967,62314,95390,57698.2 K to 90.6 K (-7.76 %)
Mar 18 2019NVUSNovus Therapeutics ...TURKEL CATHERINE C.PresidentOption ExerciseA3.7250,000186,00050,000
Mar 18 2019NVUSNovus Therapeutics ...TURKEL CATHERINE C.PresidentGrantA0.0020,000098,19978.2 K to 98.2 K (+25.58 %)

View all CATHERINE C. TURKEL insider transactions.